All speakers
Maxim Kholin
Co-Founder, Gero
Max Kholin is Co-Founder of GERO, a biotechnology company applying AI and physics-based generative models to drug discovery in aging and age-related diseases. At GERO, he leads business development, strategic partnerships, and investor relations, working at the intersection of longevity science, data-driven biology, and therapeutic development. Previously, Max co-founded and served as CEO of Quantum Pharmaceuticals, where he led molecular modeling–based drug discovery and translational research for novel small-molecule therapies. His work focuses on developing precision approaches to understanding aging biology and advancing interventions targeting chronic and age-related conditions through AI-enabled research.